Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoringÁgueda Molinos-Quintana, Josè Antonio Pérez-Simón, José María Pérez‐Hurtado et al.|Frontiers in Immunology|2024Cited by 21
Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)María Isabel Benítez‐Carabante, Cristina Díaz de Heredia, David Bueno et al.|Transplantation and Cellular Therapy|2024Cited by 13
CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantationMelissa Panesso, Cristina Díaz de Heredia, María Luz Uria Oficialdegui et al.|Frontiers in Pediatrics|2023Cited by 7
Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experienceMaria Pérez-Torres Lobato, Cristina Díaz de Heredia, María Isabel Benítez‐Carabante et al.|Frontiers in Pediatrics|2024Cited by 4
Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético)Luisa Sisinni, Cristina Díaz de Heredia, Gerardo Xavier Aguilar Monserrate et al.|Transplantation and Cellular Therapy|2024Cited by 3